SBFM insider trading
NasdaqCM HealthcareSunshine Biopharma Inc.: insider trade history from SEC Form 4 filings.
About Sunshine Biopharma Inc.
Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Company website: sunshinebiopharma.com
SBFM insider activity at a glance
FilingIQ tracks 51 insider transactions for SBFM in filings since Jan 22, 2015. The most recent transaction is dated Aug 7, 2026.
Across the full history, 6 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on SBFM insider trades is 68.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest SBFM Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for SBFM?
- FilingIQ tracks 51 Form 4 insider transactions for SBFM (Sunshine Biopharma Inc.), covering filings from Jan 22, 2015 onwards. 1 of those are dated within the last 90 days.
- Are SBFM insiders net buyers or net sellers?
- Across the full Form 4 history for SBFM, 6 transactions (12%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does SBFM insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is SBFM in?
- Sunshine Biopharma Inc. (SBFM) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $5.69M.
Methodology & sources
Every SBFM insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.